Osteosarcoma: Clinical Trials

3 trials for Osteosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 suspended. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Suspended 3
Phase 11Suspended 1
Phase 31Suspended 1

Follow Osteosarcoma: new trials by email Literature Review of Osteosarcoma trials Research Report on Osteosarcoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
PEN-866, Vincristine, Temozolomide - Sarcoma, Ewing, Rhabdomyosarcoma
Phase 1 / Phase 2SuspendedNational Cancer Institute (NCI)642024-10-312026-03-16
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Bone Scan, Cabozantinib S-malate, Cisplatin - High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2 / Phase 3SuspendedNational Cancer Institute (NCI)11222023-03-032026-10-27
Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma
apatinib - Effect of Drug, Toxicity, Drug
Phase 2SuspendedPeking University People's Hospital442021-04-012024-05-14

Narrower conditions

Drug-Related Side Effects and Adverse Reactions (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma (1)  ·  Sarcoma, Ewing (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Bone Tissue (3)  ·  Neoplasms, Connective Tissue (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Sarcoma (2)  ·  Chemically-Induced Disorders (1)  ·  Myosarcoma (1)  ·  Neoplasms, Muscle Tissue (1)

Interventions

1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Cisplatin (1)  ·  Doxorubicin (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Methotrexate (1)  ·  Phantoms, Imaging (1)  ·  Platinum (1)  ·  Surgical Procedures, Operative (1)  ·  Temozolomide (1)  ·  Vincristine (1)  ·  X-Rays (1)  ·  apatinib (1)  ·  cabozantinib (1)  ·  merphos (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Peking University People's Hospital (1)

Countries

United States (2)  ·  Australia (1)  ·  Canada (1)  ·  China (1)  ·  New Zealand (1)

Top investigators

Christine M Heske, M.D. (1)  ·  Michael W Bishop (1)  ·  Wei Guo, M.D. (1)

NIH funding

U10CA180886 (1)